Tag Archives: Urticaria

Novartis Reports Positive Phase III Outcomes for Novel Chronic Spontaneous Urticaria Drug

Posted on 9, August 2023 by

TOP-LINE DATA FROM REMIX-1 AND REMIX-2 STUDIES DEMONSTRATE SIGNIFICANT SYMPTOM IMPROVEMENT (IN BRIEF) Novartis has unveiled promising results from Phase III trials for remibrutinib, a potent Bruton’s tyrosine kinase (BTK) inhibitor, targeting chronic spontaneous urticaria (CSU). The REMIX-1 and REMIX-2 … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Science, Switzerland

Tagged , , , , , , ,